Association between trypotphan hydroxylase 2, performance on a continuance performance test and response to methylphenidate in ADHD participants

American Journal of Medical Genetics, Part B: Neuropsychiatric Genetics

Volumn 147, Issue 8, 2008, Pages 1501-1508

  Manor, Iris ^a,b   Laiba, Efrat ^c   Eisenberg, Jacques ^d   Meidad, Sheera ^a   Lerer, Elad ^c   Israel, Salomon ^c   Gritsenko, Inga ^d   Tyano, Sam ^a   Faraone, Stephen V ^e   Ebstein, Richard P ^c,d  

^a GEHA MENTAL HEALTH CENTER   (Israel)

^b TEL AVIV UNIVERSITY   (Israel)

^c HEBREW UNIVERSITY OF JERUSALEM   (Israel)

^d HERZOG HOSPITAL   (Israel)

^e SUNY UPSTATE MEDICAL UNIVERSITY   (United States)

Author keywords

ADHD; Association; Methylphenidate; T.O.V.A.; TPH2

Indexed keywords

METHYLPHENIDATE; TRYPTOPHAN HYDROXYLASE 2; CENTRAL STIMULANT AGENT; TPH2 PROTEIN, HUMAN; TRYPTOPHAN HYDROXYLASE; UNCLASSIFIED DRUG;

ADOLESCENT; ADULT; ARTICLE; ATTENTION DEFICIT DISORDER; CHILD; CONTROLLED STUDY; DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; FAMILY; FEMALE; GENETIC ASSOCIATION; GENOTYPE; HAPLOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; NEUROPSYCHOLOGICAL TEST; PERFORMANCE; PRIORITY JOURNAL; SEROTONINERGIC SYSTEM; SINGLE NUCLEOTIDE POLYMORPHISM; STATISTICAL ANALYSIS; ALLELE; GENE LINKAGE DISEQUILIBRIUM; GENETICS; INTRON; PRESCHOOL CHILD; PROBABILITY;

ADOLESCENT; ALLELES; ATTENTION DEFICIT DISORDER WITH HYPERACTIVITY; CENTRAL NERVOUS SYSTEM STIMULANTS; CHILD; CHILD, PRESCHOOL; FEMALE; GENOTYPE; HAPLOTYPES; HUMANS; INTRONS; LINKAGE DISEQUILIBRIUM; MALE; METHYLPHENIDATE; MULTIVARIATE ANALYSIS; NEUROPSYCHOLOGICAL TESTS; POLYMORPHISM, SINGLE NUCLEOTIDE; PROBABILITY; TRYPTOPHAN HYDROXYLASE;

EID: 57349142049     PISSN: 15524841     EISSN: 1552485X     Source Type: Journal    
DOI: 10.1002/ajmg.b.30702     Document Type: Article

References (48)

1. Barrett JC, Fry B, Maller J, Daly MJ. 2005. Haploview: Analysis and visualization of LD and haplotype maps. Bioinformatics 21(2):263-265.
2. Boonstra AM, Kooij JJ, Oosterlaan J, Sergeant JA, Buitelaar JK. 2005. Does methylphenidate improve inhibition and other cognitive abilities in adults with childhood-onset ADHD? J Clin Exp Neuropsychol 27(3):278-298.
3. Brookes K, Xu X, Chen W, Zhou K, Neale B, Lowe N, Anney R, Franke B, Gill M, Ebstein R, et al. 2006. The analysis of 51 genes in DSM-IV combined type attention deficit hyperactivity disorder: Association signals in DRD4, DAT1 and 16 other genes. Mol Psychiatry 11(10):934-953.
4. Brown SM, Peet E, Manuck SB, Williamson DE, Dahl RE, Ferrell RE, Hariri AR. 2005. A regulatory variant of the human tryptophan hydroxylase-2 gene biases amygdala reactivity. Mol Psychiatry 10(9):884-888, 805.
5. Conners CK. 1998. Rating scales in attention-deficit/hyperactivity disorder: Use in assessment and treatment monitoring. J Clin Psychiatry 59(Suppl 7):24-30.
6. Delahaye NF, Barbier M, Fumoux F, Rihet P. 2007. Association analyses of NCR3 polymorphisms with P. falciparum mild malaria. Microbes Infect 9(2):160-166.
7. Domschke K, Sheehan K, Lowe N, Kirley A, Mullins C, O'Sullivan R, Freitag C, Becker T, Conroy J, Fitzgerald M, et al. 2005. Association analysis of the monoamine oxidase A and B genes with attention deficit hyperactivity disorder (ADHD) in an Irish sample: Preferential transmission of the MAO-A 941G allele to affected children. Am J Med Genet Part B 134B(1):110-114.
8. Dudbridge F. 2003. Pedigree disequilibrium tests for multilocus haplotypes. Genet Epidemiol 25(2):115-121.
9. Freedman R, Adler LE, Leonard S. 1999. Alternative phenotypes for the complex genetics of schizophrenia. Biol Psychiatry 45(5):551-558.
10. Gainetdinov RR, Wetsel WC,Jones SR, Levin ED, Jaber M, Caron MG. 1999. Role of serotonin in the paradoxical calming effect of psychostimulants on hyperactivity [see comments]. Science 283(5400):397-401.
11. Greenberg L, Kindschi RN. 1996. T.O.V.A.: Test of variables attention: Clinical guide. Los Alimitos: Universal Attention Disorders. 122 p.
12. Greenberg LM, Waldman ID. 1993. Developmental normative data on the test of variables of attention (T. O.V.A.). J Child Psychol Psychiatry 34(6):1019-1030.
13. Greenberg L, Kindschi CL, Corman CM. 2000. TOVA: Test of variables of attention. Los Alamitos, CA: Universal Attention Disorders, Inc.
14. Huang YS, Chao CC, Wu YY, Chen YY, Chen CK. 2007. Acute effects of methylphenidate on performance during the Test of Variables of Attention in children with attention deficit/hyperactivity disorder. Psychiatry Clin Neurosci 61(3):219-225.
15. Kotler M, Manor I, Sever Y, Eisenberg J, Cohen H, Ebstein RP, Tyano S. 2000. Failure to replicate an excess of the long dopamine D4 exon III repeat polymorphism in ADHD in a family-based study [In Process Citation]. Am J Med Genet 96(3):278-281.
16. Kuczenski R, Segal DS. 1997. Effects of methylphenidate on extracellular dopamine, serotonin, and norepinephrine: Comparison with amphetamine. J Neurochem 68(5):2032-2037.
17. Kuntsi J, Neale BM, Chen W, Faraone SV, Asherson P. 2006. The IMAGE project: Methodological issues for the molecular genetic analysis of ADHD. Behav Brain Funct 2:27.
18. Lange C, Silverman EK, Xu X, Weiss ST, Laird NM. 2003. A multivariate family-based association test using generalized estimating equations: FBAT-GEE. Biostatistics 4(2):195-206.
19. Lasky-Su J, Banaschewski T, Buitelaar J, Franke B, Brookes K, Sonuga-Barke E, Ebstein R, Eisenberg J, Gill M, Manor I, et al. 2007. Partial replication of a DRD4 association in ADHD individuals using a statistically derived quantitative trait for ADHD in a family-based association test. Biol Psychiatry 62(9):985-990.
20. Li J, Wang YF, Zhou RL, Zhang HB, Wang B, Yang L. 2004. Association between serotonin 2C gene polymorphisms and attention deficit hyperactivity disorder comorbid or not comorbid with learning disorder. Beijing Da Xue Xue Bao 36(4):366-369.
21. Lim JE, Pinsonneault J, Sadee W, Saffen D. 2007. Tryptophan hydroxylase 2 (TPH2) haplotypes predict levels of TPH2 mRNA expression in human pons. Mol Psychiatry 12(5):491-501.
22. Ma JZ, Beuten J, Payne TJ, Dupont RT, Elston RC, Li MD. 2005. Haplotype analysis indicates an association between the DOPA decarboxylase (DDC) gene and nicotine dependence. Hum Mol Genet 14(12):1691-1698.
23. Madras BK, Miller GM, Fischman AJ. 2005. The dopamine transporter and attention-deficit/hyperactivity disorder. Biol Psychiatry 57(11):1397-1409.
24. Mann JJ, Currier D. 2007. A review of prospective studies of biologic predictors of suicidal behavior in mood disorders. Arch Suicide Res 11(1):3-16.
25. Manor I, Eisenberg J, Tyano S, Sever Y, Cohen H, Ebstein RP, Kotler M. 2001. Family-based association study of the serotonin transporter promoter region polymorphism (5-HTTLPR) in attention deficit hyperactivity disorder. Am J Med Genet 105(1):91-95.
26. Manor I, Tyano S, Eisenberg J, Bachner-Melman R, Kotler M, Ebstein RP. 2002a. The short DRD4 repeats confer risk to attention deficit hyperactivity disorder in a family-based design and impair performance on a continuous performance test (TOVA). Mol Psychiatry 7(7):790-794.
27. Manor I, Tyano S, Mel E, Eisenberg J, Bachner-Melman R, Kotler M, Ebstein RP. 2002b. Family-based and association studies of monoamine oxidase A and attention deficit hyperactivity disorder (ADHD): Preferential transmission of the long promoter-region repeat and its association with impaired performance on a continuous performance test (TOVA). Mol Psychiatry 7(6):626-632.
28. Manor I, Corbex M, Eisenberg J, Gritsenkso I, Bachner-Melman R, Tyano S, Ebstein RP. 2004. Association of the dopamine D5 receptor with attention deficit hyperactivity disorder (ADHD) and scores on a continuous performance test (TOVA). Am J Med Genet 127(1):73-77.
29. Neale BM, Sham PC. 2004. The future of association studies: Gene-based analysis and replication. Am J Hum Genet 75(3):353-362.
30. Oades RD. 2000. Differential measures of 'sustained attention' in children with attention-deficit/hyperactivity or tic disorders: Relations to monoamine metabolism. Psychiatry Res 93(2):165-178.
31. Oades RD. 2002. Dopamine may be 'hyper' with respect to noradrenaline metabolism, but 'hypo' with respect to serotonin metabolism in children with attention-deficit hyperactivity disorder. Behav Brain Res 130(1-2):97-102.
32. Preston AS, Fennell EB, Bussing R. 2005. Utility of a CPT in diagnosing ADHD among a representative sample of high-risk children: A cautionary study. Child Neuropsychol 11(5):459-469.
33. Retz W, Thome J, Blocher D, Baader M, Rosler M. 2002. Association of attention deficit hyperactivity disorder-related psychopathology and personality traits with the serotonin transporter promoter region polymorphism. Neurosci Lett 319(3):133-136.
34. Sheehan K, Hawi Z, Gill M, Kent L. 2007. No association between TPH2 gene polymorphisms and ADHD in a UK sample. 412(2):105-107.
35. Sheehan K, Lowe N, Kirley A, Mullins C, Fitzgerald M, Gill M, Hawi Z. 2005. Tryptophan hydroxylase 2 (TPH2) gene variants associated with ADHD. Mol Psychiatry 10(10):944-949.
36. Smoller JW, Biederman J, Arbeitman L, Doyle AE, Fagerness J, Perlis RH, Sklar P, Faraone SV. 2006. Association between the 5HT1B receptor gene (HTR1B) and the inattentive subtype of ADHD. Biol Psychiatry 59(5):460-467.
37. Steen KV, Lange C. 2005. PBAT: A comprehensive software package for genome-wide association analysis of complex family-based studies. Hum Genomics 2(1):67-69.
38. Szobot CM, Ketzer C, Parente MA, Biederman J, Rohde LA. 2004. The acute effect of methylphenidate in Brazilian male children and adolescents with ADHD: A randomized clinical trial. J Atten Disord 8(2):37-43.
39. Waldman ID, Gizer IR. 2006. The genetics of attention deficit hyperactivity disorder. Clin Psychol Rev 26(4):396-432.
40. Walitza S, Renner TJ, Dempfle A, Konrad K, Wewetzer C, Halbach A, Herpertz-Dahlmann B, Remschmidt H, Smidt J, Linder M, et al. 2005. Transmission disequilibrium of polymorphic variants in the tryptophan hydroxylase-2 gene in attention-deficit/hyperactivity disorder. Mol Psychiatry 10(12):1126-1132.
41. Walther DJ, Bader M. 2003. A unique central tryptophan hydroxylase isoform. Biochem Pharmacol 66(9):1673-1680.
42. Willcutt EG, Doyle AE, Nigg JT, Faraone SV, Pennington BF. 2005. Validity of the executive function theory of attention-deficit/hyperactivity disorder: A meta-analytic review. Biol Psychiatry 57(11):1336-1346.
43. Zeger SL, Liang KY. 1986. Longitudinal data analysis for discrete and continuous outcomes. Biometrics 42(1):121-130.
44. Zhang J, Rowe WL, Clark AG, Buetow KH. 2003. Genomewide distribution of high-frequency, completely mismatching SNP haplotype pairs observed to be common across human populations. Am J Hum Genet 73(5):1073-1081.
45. Zhou Z, Roy A, Lipsky R, Kuchipudi K, Zhu G, Taubman J, Enoch MA, VirkkunenM,Goldman D. 2005. Haplotype-based linkage of tryptophan hydroxylase 2 to suicide attempt, major depression, and cerebrospinal fluid 5-hydroxyindoleacetic acid in 4 populations. Arch Gen Psychiatry 62(10):1109-1118.
46. Zill P, Baghai TC, Zwanzger P, Schule C, Eser D, Rupprecht R, Moller HJ, Bondy B, Ackenheil M. 2004a. SNP and haplotype analysis of a novel tryptophan hydroxylase isoform (TPH2) gene provide evidence for association with major depression. Mol Psychiatry 9(11):1030-1036.
47. Zill P, Buttner A, Eisenmenger W, Moller HJ, Bondy B, Ackenheil M, 2004b Single nucleotide polymorphism and haplotype analysis of a novel tryptophan hydroxylase isoform (TPH2) gene in suicide victims. Biol Psychiatry 56(8):581-586.
48. Zoroglu SS, Erdal ME, Alasehirli B, Erdal N, Sivasli E, Tutkun H, Savas HA, Herken H. 2002. Significance of serotonin transporter gene 5-HTTLPR and variable number of tandem repeat polymorphism in attention deficit hyperactivity disorder. Neuropsychobiology 45(4):176-181.